1. Introduction {#sec1}
===============

Breast cancer is increasingly common in women worldwide. It is one of the leading causes of death among female malignancies \[[@B1]\]. The incidence varies from region to region, more in developed countries (\>80 per 100,000 populations) than in developing countries (\<40 per 100,000 populations). In southeast Asian women, it was 31.0 per 100,000 populations \[[@B2]\]. Cancer of the breast in Thailand is the highest among all female cancers and is continuously rising. The incidence increased from 34.4 to 40.6 per 100,000 populations during 2006 to 2009. The mortality also increased from 6.3 to 7.3 per 100,000 populations in the corresponding years \[[@B3]\].

The standard diagnosis of breast cancer recommended triple diagnostic investigations \[[@B4]\], comprising (1) clinical breast examination; (2) breast imaging, ultrasonography, or mammography, (3) cytopathologic with fine needle aspiration cytology (FNAC) or histopathologic findings with a core needle biopsy with cutting needle biopsy. The same recommendation was also used by The National Institute of Cancer of Thailand, for women presenting with breast lumps \[[@B5]\]. Ultrasonography is recommended in women under 35 years old, and both ultrasonography and mammography are recommended in those 35 years old or above. Although breast images have been proved effective in diagnosing cancer in women presenting with breast lumps \[[@B6]\], their uses are, however, limited, either by lack of trained medical personnel or their unavailability. Referral of patients to better equipped hospitals only for imaging investigations may somehow cause the delay in diagnosis and treatments \[[@B7]\].

In routine practice, physicians in countries with limited resources approach women with breast lumps with history taking clinical breast examination and breast pathology by FNAC or biopsy and skipped breast imaging (mammography or ultrasonography) to shorten the time of diagnosis and treatment. However, clinical breast examination alone lacks reliability for cancer diagnosis \[[@B8]\]. Although researches indicated that diagnosis of cancer may be adequately made by FNAC \[[@B7]\], the results may still contain false-negatives and false-positives \[[@B9]\]. The procedure (FNAC) also cannot differentiate in situ from invasive breast cancer. There are still not enough evidences to conclude which investigations should be used when considering effectiveness together with availability, leading to varying recommendations and guidelines \[[@B10]\].

The present study evaluated the ability of breast imaging (mammography and ultrasonography) in diagnosing cancer in women presenting with breast lumps, in the presence of patient profiles, with or without FNAC. The study also considered their combinations, sequences, and availability of each investigative modality, in order to reflect situations where health resources are limited.

2. Subjects and Methods {#sec2}
=======================

2.1. Subjects and Settings {#sec2.1}
--------------------------

Patients were women who presented with breast lumps in two university-affiliated tertiary care hospitals, Lampang Hospital and Uttaradit Hospital, located in the northern part of Thailand. Patient medical records between 2006 and 2010 were retrieved under the ICD-10 specification. Case tracing was made for at least 12 months after the first presentation to the hospitals to verify any changes in final diagnosis. Women with a history of breast biopsy, or breast silicone implantation were not included. In this nested case-control analogue design, cases were women verified as cancer by breast pathology (biopsy or operative specimen). Controls were those with noncancerous lumps proved by the same criteria or clinical breast examination and/or breast imaging and/or FNAC.

2.2. Data and Source {#sec2.2}
--------------------

The keyed information, age (years), body mass index (BMI, kg/m^2^), duration of lumps (month), size of lumps (cm), side of lumps, quadrant, clinical characteristics, and final histopathology, was retrieved from the medical registration and patient records.

2.3. Diagnostic Investigations {#sec2.3}
------------------------------

For breast imaging results, mammography and ultrasonography were interpreted by the hospital radiologists under routine practices. The classification of breast imaging followed the BI-RADS (Breast Imaging Reporting and Data System) \[[@B11]\] ([Table 1](#tab1){ref-type="table"}).

Cytopathologic diagnosis was verified by certified university hospital pathologists. FNAC classification followed the Cytologic Category Code System \[[@B12], [@B13]\] ([Table 1](#tab1){ref-type="table"}).

2.4. Data Analysis {#sec2.4}
------------------

General characteristics and clinical characteristics were presented with descriptive statistics and compared between patients with and without cancer by exact probability tests, *t*-tests, or Wilcoxon\'s rank sum tests, as appropriate.

Logistic regression techniques were used to obtain diagnostic values of age, size, imaging techniques, and FNAC and presented with diagnostic odds ratios (dORs), 95% confidence interval (CI), and *P* value.

The diagnostic abilities of the 3 main diagnostic investigations (ultrasonography, mammography, and FNAC) in combination with clinical baseline (age and size of lumps) were compared with the clinical baseline alone, by area under the receiver operating characteristics (AuROCs) curves.

The differences in predictive abilities of diagnostic modality were compared by the likelihood ratio tests (LR tests) under the logistic models. Application utilities of the investigation sequences were calculated by predictive ability (%) times availability (%) to guide clinical approaches in real situations.

3. Results {#sec3}
==========

From 3129 breast lumps (3069 patients), there were 854 lumps with definite (postoperative histopathology) diagnosis of breast cancer and 2275 lumps without. Review of the index investigation, ultrasonography, mammography, and FNAC showed significant different results between those with and without cancer (*P* \< 0.001) ([Table 1](#tab1){ref-type="table"}).

Patients were between 15 and 93 years old (mean = 45.8 ± 12.8). Those with cancer were older (53.2 ± 11.6 versus 43.1 ± 12.0 years, *P* \< 0.001) and had higher body mass index (23.7 ± 6.2 versus 22.7 ± 2.2 kg/m^2^, *P* = 0.003). The duration of noticing breast lumps was shorter (4.0 ± 9.9 versus 4.4 ± 14.0 months, *P* \< 0.001). Lump sizes ranged from 0.5 to 15 cm, larger in those with cancer (3.1 ± 1.9 versus 1.6 ± 1.1 cm, *P* \< 0.001). More than half of the lumps were palpable in the upper outer quadrants. Right and left sided lumps were similar in both groups. Fixed lumps, retracted skin, and retracted nipple were more frequent in those with cancer (*P* \< 0.001) ([Table 2](#tab2){ref-type="table"}).

The independent predictive ability of the three investigative modalities in the presence of baseline information (age and size) under the multivariable logistic regression showed high diagnostic odds ratios of 3.85 for ultrasonography, 2.08 for mammography, and 3.52 for FNAC ([Table 3](#tab3){ref-type="table"}).

Baseline information, age and lump sizes, alone predicted cancer correctly in 77.45% (AuROC = 77.45, 95% CI = 73.31--81.60). Single investigation on top of baseline showed the highest to the lowest prediction for ultrasonography (AuROC = 96.22%, 95% CI = 94.77--97.67), mammography (AuROC = 95.99%, 95% CI = 94.46--97.52), and FNAC (AuROC = 92.47%, 95% CI = 90.32--94.62) ([Figure 1](#fig1){ref-type="fig"}).

Modality combination with the highest prediction was breast imaging (either ultrasonography or mammography) with FNAC. FNAC after ultrasonography added 2.07% (*P* \< 0.001). FNAC after mammography also increased the prediction by 2.21% (*P* \< 0.001). Ultrasonography after mammography added very little prediction (0.24%, *P* = 0.015). Ultrasonography followed by mammography also added very little prediction (0.01%, *P* = 0.609) ([Figure 2](#fig2){ref-type="fig"}).

The investigative modality sequence that yielded high additional prediction leading to high final prediction was breast imaging (either ultrasonography or mammography) followed by FNAC.

4. Discussion {#sec4}
=============

Breast imaging (either ultrasonography or mammography) increased cancer prediction beyond baseline information with AuROCs of 96.22% and 95.99%. Their utilities were among the highest (38.45% and 30.71%). Previous studies also reported high reliability of the two modalities, but there were no reports on availability or utility in routine practice, nor reports on appropriate combination or sequences of investigations \[[@B6], [@B14]--[@B18]\]. It is therefore difficult to compare diagnostic accuracies of investigative modalities across studies \[[@B7]\].

In the area with restricted health resources, clinicians may diagnose breast cancer using clinical breast examination and FNAC, without any of breast imaging modalities. The present study agreed that clinical breast examination alone was not adequate for cancer diagnosis \[[@B8], [@B19]\]. Although FNAC on top of baseline information might be efficient (AuROC = 92.47%, OR = 3.52, *P* \< 0.001) \[[@B7], [@B20]--[@B23]\], but false-negative results from FNAC may lead to delayed and/or under treatment, while false-positive results may lead to over treatment \[[@B24]\]. Additional ultrasonography or mammography after FNAC increases cancer prediction by 5.82% and 5.73%, clinically and statistically significant, but its application utility decreased profoundly to 8.36% and 7.30%.

Comparing between the two imaging modalities, ultrasonography had higher cancer prediction and utility than mammography. Mammography may have some limitations in diagnosing dense breast \[[@B25], [@B26]\], while ultrasonography may have more advantages in diagnosing breast cyst. The accuracy of ultrasonography in diagnosing cyst was as high as 92%, but only 65% in diagnosing cancer \[[@B27]\]. Ultrasonography may also detect cancer from stage 1 to stage 4. Microcalcification was detected in 74% of patients with ductal carcinoma in situ of the breast (54 in 73 patients) \[[@B28]\]. Ultrasonography also detected abnormality when mammography reported Bi-RADS = 0 \[[@B29]\]. Subgroup analysis also showed that patients with Bi-RADS below 4 might gain more benefit from additional ultrasound investigation, while for those with Bi-RADS 4 and above who already had high possibility for cancer, ultrasound might not gain any additional information.

The findings indicated that breast imaging was valuable in diagnosing cancer in patients presenting with breast lumps with high utility. In health restricted resource countries, performing both imaging modalities (ultrasonography and mammography) may be unnecessary \[[@B30]\]. However, a better prediction may be gained by a combination of different modalities ultrasonography followed by FNAC, or mammography followed by FNAC, depending on availability and/or preference.

Breast imaging investigation should therefore be encouraged and made available countrywide in order to reduce cancer mortality in women presenting with breast lumps suspicious of breast cancer \[[@B10]\].

5. Conclusions {#sec5}
==============

Breast imaging, either ultrasonography or mammography, had high additional diagnostic value of cancer prediction over baseline in patients presenting with breast lumps. However, both mammography and ultrasonography may be unnecessary. Which modality should be performed first was due to its availability and/or center preferences. However, additional FNAC, if available, may increase cancer prediction, both clinically and statistically.
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###### 

Classification of breast imaging (ultrasonography and mammography) and fine needle aspiration cytology (FNAC) investigations (3069 subjects, 3129 lumps).

  Classifications   Interpretation                       Malignant   Benign   *P* value          
  ----------------- ------------------------------------ ----------- -------- ----------- ------ ---------
  Ultrasonography                                                                                 
   bi-rads 0        Need additional imaging evaluation   0           0        4           0.3    \<0.001
   bi-rads 1        Negative                             0           0        116         8.2    
   bi-rads 2        Benign                               14          2.2      964         68.0   
   bi-rads 3        Probably benign                      20          3.2      240         16.9   
   bi-rads 4        Suspicious for abnormality           164         25.9     86          6.1    
   bi-rads 5        Highly suggestive of malignancy      435         68.7     7           0.5    
  Mammography                                                                                     
   bi-rads 0        Need additional imaging evaluation   0           0        2           0.2    \<0.001
   bi-rads 1        Negative                             0           0        88          7.4    
   bi-rads 2        Benign                               14          2.2      815         68.4   
   bi-rads 3        Probably benign                      20          3.2      198         16.6   
   bi-rads 4        Suspicious for abnormality           162         25.8     81          6.8    
   bi-rads 5        Highly suggestive of malignancy      432         68.8     7           0.6    
  FNAC                                                                                            
   class 1          Inadequate, unsatisfactory           47          9.5      86          18.4   \<0.001
   class 2          Benign cell present                  17          3.5      356         76.1   
   class 3          Probably benign                      76          15.5     24          5.1    
   class 4          Suspicious for malignancy            67          13.6     2           0.4    
   class 5          Malignant cell present               285         57.9     0           0      

###### 

General characteristics of patients (3069 subjects, 3129 lumps).

  Characteristics                    Malignant   Benign   *P* value            
  ---------------------------------- ----------- -------- ----------- -------- ---------
  Age (years)                        53.2        (11.6)   43.1        (12.0)   \<0.001
  BMI (kg/m^2^)                      23.7        (6.2)    22.7        (2.2)    0.003
  Duration (month)                   4.0         (9.9)    4.4         (14.0)   \<0.001
  Size (cm)                          3.1         (1.9)    1.6         (1.1)    \<0.001
  Side (*n*, %)                                                                 
   Right                             419         49.1     1,102       48.4     0.779
   Left                              435         50.9     1,173       51.6      
  Quadrant (*n*, %)                                                             
   Upper outer                       467         54.7     1,157       50.9     0.121
   Upper inner                       188         22.0     556         24.4      
   Subareolar                        55          6.5      145         6.4       
   Lower outer                       95          11.1     239         10.5      
   Lower inner                       49          5.7      178         7.8       
  Clinical manifestations (*n*, %)                                              
   Fixed lump                        346         47.1     40          2.5      \<0.001
   Retracted skin                    30          4.5      9           0.7      \<0.001
   Nipple discharge                  19          2.8      41          2.7      1.000
   Rugged edge                       74          10.9     141         10.3     0.702
   Wound/ulcer                       13          2.0      26          2.1      1.000

###### 

Independent effects of clinical parameters used in logistic modelling for breast cancer diagnosis, measured as multivariable diagnostic odds ratio (dOR).

  Parameters                      dOR    95% Confidence interval   *P* value
  ------------------------------- ------ ------------------------- -----------
  Age (per year)                  1.02   0.98 to 1.06              0.313
  Size (per cm)                   1.77   1.23 to 2.54              0.002
  Ultrasonography (per bi-rads)   3.85   0.80 to 18.43             0.092
  Mammography (per bi-rads)       2.08   0.44 to 9.90              0.359
  FNAC (per class)                3.52   2.45 to 5.08              \<0.001
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